[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. / Interdisziplinäre Empfehlungen zur Behandlung des metastasierten Nierenzellkarzinoms.
Aktuelle Urol
; 40(1): 27-30, 2009 Jan.
Article
en De
| MEDLINE
| ID: mdl-19177318
ABSTRACT
With the introduction of targeted therapies, a paradigm shift for the treatment of metastatic renal cell cancer has taken place. New compounds like sunitinib, sorafenib, bevacizumab and temsirolimus have become established as new therapeutic standards. An interdisciplinary consensus conference was held to discuss treatment sequences and open questions. Results from the 2007 conference provided the basis for the 2008 meeting. The results of the 2008 conference are presented as short theses.
Texto completo:
1
Bases de datos:
MEDLINE
Métodos Terapéuticos y Terapias MTCI:
Terapias_biologicas
/
Aromoterapia
Asunto principal:
Piridinas
/
Pirroles
/
Bencenosulfonatos
/
Carcinoma de Células Renales
/
Sirolimus
/
Inhibidores de la Angiogénesis
/
Inhibidores de Proteínas Quinasas
/
Indoles
/
Neoplasias Renales
/
Anticuerpos Monoclonales
Tipo de estudio:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Idioma:
De
Revista:
Aktuelle Urol
Año:
2009
Tipo del documento:
Article